Medgend Icon

Ledgend of Medicine







discontinued


Lupron Depot FDA Approved Drugs

ELIGARD [Leuprolide AcetateC59H84N16O12C2H4O2]
RX
-
22.5mg/vial (subcutaneous injectable)
30mg/vial (subcutaneous injectable)
45mg/vial (subcutaneous injectable)
7.5mg/vial (subcutaneous injectable)
Tolmar TherapJul 24, 2002
  • Method of treating cancer.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LEUPROLIDE ACETATE [Leuprolide AcetateC59H84N16O12C2H4O2]
RX
-
1mg/0.2ml (injection injectable)
SandozAug 4, 1998
Sun Pharma GlobalMar 9, 2009
Teva Pharms UsaOct 25, 2000
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LUPRON DEPOT [Leuprolide AcetateC59H84N16O12C2H4O2]
RX
-
11.25mg/vial (injection injectable)
22.5mg/vial (injection injectable)
3.75mg (injection injectable)
30mg/vial (injection injectable)
45mg/vial (injection injectable)
7.5mg/vial (injection injectable)
Abbvie Endocrine IncMar 7, 1997
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LUPRON DEPOT-PED [Leuprolide AcetateC59H84N16O12C2H4O2]
RX
-
11.25mg/vial (injection injectable)
15mg/vial (injection injectable)
30mg/vial (injection injectable)
7.5mg/vial (injection injectable)
Abbvie Endocrine IncAug 15, 2011
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.